Seroprevalence of Kaposi's sarcoma-associated herpesvirus among HIV-infected Uygurs in Xinjiang, China

被引:9
|
作者
Liu, Zhenqiu [1 ,2 ,3 ]
Fang, Qiwen [1 ,2 ,3 ]
Zhou, Sujuan [1 ,2 ,3 ]
Minhas, Veenu [4 ,5 ]
Wood, Charles [4 ,5 ]
He, Na [1 ,2 ,3 ]
Zhang, Tiejun [1 ,2 ,3 ]
机构
[1] Fudan Univ, Sch Publ Hlth, Dept Epidemiol, Shanghai, Peoples R China
[2] Fudan Univ, Key Lab Publ Hlth Safety, Minist Educ, Shanghai, Peoples R China
[3] Fudan Univ, Collaborat Innovat Ctr Social Risks Governance Hl, Shanghai, Peoples R China
[4] Univ Nebraska, Nebraska Ctr Virol, Lincoln, NE USA
[5] Univ Nebraska, Sch Biol Sci, Lincoln, NE USA
基金
上海市自然科学基金; 美国国家卫生研究院; 国家教育部博士点专项基金资助;
关键词
China; HIV; KSHV; HUMAN-IMMUNODEFICIENCY-VIRUS; ANTIRETROVIRAL THERAPY; UNITED-STATES; RISK-FACTORS; MOLECULAR EPIDEMIOLOGY; GENOTYPIC ANALYSIS; HUMAN-HERPESVIRUS-8; VARIABILITY; POPULATION; PREVALENCE;
D O I
10.1002/jmv.24804
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Kaposi's sarcoma-associated herpesvirus (KSHV) is the etiological agent of Kaposi's sarcoma (KS), which primarily affects human immunodeficiency virus (HIV)-infected adults with advanced immunodeficiency. Xinjiang province in China is an endemic area for Kaposi's sarcoma (KS), however, currently, only limited data for KSHV infection among HIV-infected individuals living in this endemic area is available. A cross-sectional study of 86 HIV positive participants was conducted in Xinjiang, China from 2014 through 2015. Plasma samples were collected and screened for KSHV and HIV infection. HIV pol gene and KSHV ORF-K1 gene were amplified and sequenced, genotypes were determined by phylogenetic analysis. Over all, prevalence was 48.9% (42/86; 95% CI 38.4-59.3%) for KSHV. Only CRF07_BC subtype has been identified among all these HIV positive individuals, while the subtype A and C of KSHV were detected in the participants. Meanwhile, we found that those with high CD4 counts (>500) showed a lower anti-KSHV titer, compared with other groups. Our study indicated a high prevalence of KSHV among HIV positive individuals in Xinjiang, China. Thus, management of HIV/AIDS patients should include KSHV screen and should consider the risk of KSHV-associated malignancies.
引用
收藏
页码:1629 / 1635
页数:7
相关论文
共 50 条
  • [1] Seroprevalence of Kaposi's Sarcoma-Associated Herpesvirus and Risk Factors in Xinjiang, China
    Fu, Bishi
    Sun, Feng
    Li, Baolin
    Yang, Lei
    Zeng, Yan
    Sun, Xiulian
    Xu, Fanhong
    Rayner, Simon
    Guadalupe, Moraima
    Gao, Shou-Jiang
    Wang, Linding
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2009, 81 (08) : 1422 - 1431
  • [2] Seroprevalence and Determinants of Kaposi Sarcoma-Associated Human Herpesvirus 8 in Indian HIV-Infected Males
    Munawwar, Arshi
    Sharma, Surendra K.
    Gupta, Somesh
    Singh, Sarman
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 2014, 30 (12) : 1192 - 1196
  • [3] Seroprevalence of antibodies against Kaposi's sarcoma-associated herpesvirus among HIV-negative people in China
    Zhang, Tiejun
    Liu, Zhenqiu
    Wang, Jun
    Minhas, Veenu
    Wood, Charles
    Clifford, Gary M.
    He, Na
    Franceschi, Silvia
    [J]. INFECTIOUS AGENTS AND CANCER, 2017, 12
  • [4] Seroprevalence of antibodies against Kaposi's sarcoma-associated herpesvirus among HIV-negative people in China
    Tiejun Zhang
    Zhenqiu Liu
    Jun Wang
    Veenu Minhas
    Charles Wood
    Gary M. Clifford
    Na He
    Silvia Franceschi
    [J]. Infectious Agents and Cancer, 12
  • [5] Genotypic Analysis of Kaposi's Sarcoma-Associated Herpesvirus from Patients with Kaposi's Sarcoma in Xinjiang, China
    Ouyang, Xinxing
    Zeng, Yan
    Fu, Bishi
    Wang, Xiaowu
    Chen, Wei
    Fang, Yuan
    Luo, Minhua
    Wang, Linding
    [J]. VIRUSES-BASEL, 2014, 6 (12): : 4800 - 4810
  • [6] Effects of Antiretroviral Therapy on Kaposi's Sarcoma-Associated Herpesvirus (KSHV) Transmission Among HIV-Infected Zambian Children
    Olp, Landon N.
    Minhas, Veenu
    Gondwe, Clement
    Kankasa, Chipepo
    Wojcicki, Janet
    Mitchell, Charles
    West, John T.
    Wood, Charles
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2015, 107 (10)
  • [7] Seroprevalence of Kaposi's sarcoma-associated herpesvirus and risk factors in Jiuquan area, China
    Fang, Yuan
    Li, Wenli
    Zhang, Ying
    Zhou, Chang
    Wu, Huanwu
    Zhang, Yiting
    Dai, Tao
    Wang, Jinzhi
    Wang, Lei
    Chen, Tongqing
    Zhu, Yulin
    Wang, Linding
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2022, 94 (12) : 6016 - 6022
  • [8] Kaposi's sarcoma-associated herpesvirus and Kaposi's sarcoma
    Gruffat, H
    Sergeant, A
    Manet, E
    [J]. MICROBES AND INFECTION, 2000, 2 (06) : 671 - 680
  • [9] Seroprevalence of Kaposi's sarcoma-associated herpesvirus in healthy adults in Israel
    Iscovich, J
    Fischbein, A
    Fisher-Fischbein, J
    Freedman, LS
    Eng, SM
    Boffetta, P
    Vudovich, A
    Glasman, C
    Goldschmidt, R
    Livingston, M
    Heger-Maslansky, B
    Brennan, P
    Moore, PS
    [J]. ANTICANCER RESEARCH, 2000, 20 (3B) : 2119 - 2122
  • [10] Seroprevalence of Kaposi's sarcoma-associated herpesvirus in various populations in Cuba
    Kourí, V
    Eng, SM
    Rodríguez, ME
    Resik, S
    Orraca, O
    Moore, PS
    Chang, Y
    [J]. REVISTA PANAMERICANA DE SALUD PUBLICA-PAN AMERICAN JOURNAL OF PUBLIC HEALTH, 2004, 15 (05): : 320 - 325